-
SpyGlass Pharma (SGP) Misses Q4 EPS by 572c
-
H.C. Wainwright Starts SpyGlass Pharma (SGP) at Buy
-
Leerink Partners Starts SpyGlass Pharma (SGP) at Outperform
-
Jefferies Starts SpyGlass Pharma (SGP) at Buy
-
Citi Starts SpyGlass Pharma (SGP) at Buy
-
Stifel Starts SpyGlass Pharma (SGP) at Buy
-
SpyGlass Pharma (SGP) resumes trading, up 103%
-
SpyGlass Pharma (SGP) files for 9.375M share IPO at $15-$17/sh
-
SpyGlass Pharma (SGP) files for proposed IPO

